Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

New differentiation-inducing vitamin D compounds from Japanese lab

March 30, 1999

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

March 30, 1999

Bioniche technology offers synergistic benefits in cancer therapy

March 29, 1999

Sugen's new protein tyrosine kinase inhibitors

March 26, 1999

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

MethylGene initiates phase I clinical trials of MG-98 for solid tumors

March 25, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...